Artículos de revistas
The Effect Of Milk On Plasmatic And Tissue Levels Of Macrolides: In Vivo Study In Rats
Registro en:
Revista De Ciencias Farmaceuticas Basica E Aplicada. , v. 26, n. 2, p. 113 - 118, 2005.
18084532
2-s2.0-33745667781
Autor
Del Fiol F.D.S.
Toledo M.I.
Groppo F.C.
Institución
Resumen
The ingestion of milk with drugs, particularly some antibiotics, is frequently recommended in order to decrease possible gastrointestinal discomfort. The objective of this study was to assess the interference of milk in the absorption and tissue levels of macrolide antibiotics (erythromycin, clarithromycin, roxithromycin and azithromycin). Forty female rats received surgically-implanted PVC sponges on their backs. One week later, granulomatous tissue was observed and the animals were divided into eight groups, which received erythromycin, clarithromycin, roxithromycin and azithromycin with and without milk. One hour after administration of antibiotic, the animals were sacrificed. The serum and tissue samples were submitted to microbiological assay with Micrococcus luteus ATCC 9341, in order to determine drug concentration. Milk did not cause any reduction in the serum and tissue levels of azithromycin and clarithromycin (p>0.05, β-test). However, ingestion of milk reduced by approximately 28.7% the roxithromycin (p<0.0001, t-test) and by 34.1% the erythromycin (p<0.0001, t test) serum concentrations. Similar effects were observed on tissue levels. Milk ingestion caused a reduction of approximately 20.8% in the roxithromycin p<0.0001, t-test) and 40% in the erythromycin (p<0.0001, β-test) tissue levels. We concluded that erythromycin and roxithromycin should be not administered with milk. 26 2 113 118 Anderson, G., Esmonde, T.S., Coles, S., Macklin, J., Carnegie, C., A comparative safety and efficacy study of clarithromycin and erythromycin stearate in community-acquired pneumonia (1991) J Antimicrob Chemother, 27 (SUPPL. A), pp. 117-124 Blandizzi, C., Malizia, T., Lupetti, A., Pesce, D., Gabriele, M., Giuca, M.R., Campa, M., Senesi, S., Periodontal tissue disposition of azithromycin in patients affected by chronic inflammatory periodontal diseases (1999) J Periodontol., 70 (9), pp. 960-966 Bowler, W.A., Hostettler, C., Samuelson, D., Lavin, B.S., Oldfield, E., Gastrointestinal side effects of intravenous erythromycin: Incidence and reduction with prolonged infusion time and glycopyrrolate pretreatment (1992) Am J Med, 92 (3), pp. 249-253 Charles, L., Segreti, J., Choosing the right macrolide antibiotic. A guide to selection (1997) Drugs, 53 (3), pp. 349-357 Charman, W.N., Porter, C.J., Mithani, S., Dressman, J.B., Physiochemical and physiological mechanisms for the effects of food on drug absorption: The role of lipids and pH (1997) J Pharm Sci, 86 (3), pp. 269-282 Danesi, R., Lupetti, A., Barbara, C., Ghelardi, E., Chella, A., Malizia, T., Senesi, S., Campa, M., Comparative distribution of azithromycin in lung tissue of patients given oral daily doses of 500 and 1000 mg (2003) J Antimicrob Chemother, 51 (4), pp. 939-945 Dreassi, E., Corti, P., Bezzini, F., Furlanetto, S., High-performance liquid chromatographic assay of erythromycin from biological matrix using electrochemical or ultraviolet detection (2000) Analyst, 125 (6), pp. 1077-1081 Fiol, F.S.D., Mattos Filho, T.R., Groppo, F.C., Evaluation in an animal model and in vitro of the combination clavulanic acid and cephalosporins against beta-lactamase producing and nonproducing Staphylococcus aureus strains (2000) Braz J Infect Dis, 4 (1), pp. 36-42 Fleisher, D., Li, C., Zhou, Y., Pao, L.H., Karim, A., Drug, meal and formulation interactions influencing drug absorption after oral administration. Clinical implications (1999) Clin Pharmucokinet, 36 (3), pp. 233-254 Goudah, A., Abo El-Sooud, K., Abd El-Aty, A.M., Pharmacokinetics and tissue residue profiles of erythromycin in broiler chickens after different routes of administration (2004) Dtsch Tierarztl Wochenschr, 111 (4), pp. 162-165 Groppo, F.C., Mattos-Filho, T.R., Del-Fiol, F.S., Bioassay of amoxicillin in rats (2000) Biol Pharm Bull, 23 (9), pp. 1033-1035 Groppo, F.C., Simões, R.P., Ramacciato, J.C., Render, V., Andrade, E.D., Mattos-Filho, T.R., Effect of sodium diclofenac on serum and tissue concentration of amoxicillin and on staphylococcal infection (2004) Biol Pharm Bull, 27 (1), pp. 52-55 Guay, D.R., Gustavson, L.E., Devcich, K.J., Zhang, J., Cao, G., Olson, C.A., Pharmacokinetics and tolerability of extended-release clarithromycin (2001) Clin Ther, 23 (4), pp. 566-577 Hamilton-Miller, J., In-vitro activities of 14-, 15- Und 16-membered macrolides against gram-positive cocci (1992) J Antimicrob Chemother, 29 (2), pp. 141-147 Harpster, C.P., Katz, S.E., Improved microbiological procedure for determining erythromycin in milk and some milk products (1980) J Assoc off Anal Chem, 63 (5), pp. 1144-1148 Hsu, M.C., Hsu, P.W., High-performance liquid chromatographic method for potency determination of amoxicillin in commercial preparations and for stability studies (1992) Antimicrob Agents Chemother, 36 (6), pp. 1276-1279 Lakritz, J., Wilson, W.D., Marsh, A.E., Mihalyi, J.E., Effects of prior feeding on pharmacokinetics and estimated bioavailability after oral administration of a single dose of microencapsulated erythromycin base in healthy foals (2000) Am J Vet Res, 61 (9), pp. 1011-1015 Lassman, H.B., Puri, S.K., Ho, I., Sabo, R., Mezzino, M.J., Pharmacokinetics of roxithromycin (RU 965) (1988) J Clin Pharmacol, 28 (2), pp. 141-152 Latare, P.A., Setness, P.A., Using erythromycin. Some helpful observations (1989) Postgrad Med, 86 (1), pp. 55-59 Levenstein, J.H., Clarithromycin versus penicillin in the treatment of streptococcal pharyngitis (1991) J Antimicrob Chemother, 27 (SUPPL. A), pp. 67-74 Lewis, C.W., Frongillo, E.A., Roe, D.A., Drug-nutrient interactions in three long-term-care facilities (1995) J Am Diet Assoc, 95 (3), pp. 309-315 Li, X.Q., Zhong, D.F., Huang, H.H., Wu, S.D., Demethylation metabolism of roxithromycin in humans and rats (2001) Acta Pharmacol Sin, 22 (5), pp. 469-474 Maganti, K., Onyemere, K., Oral erythromycin and symptomatic relief of gastroparesis: A systematic review (2003) Am J Gastroenterol, 98 (2), pp. 259-263 Malizia, T., Tejada, M.R., Ghelardi, E., Senesi, S., Gabriele, M., Giuca, M.R., Blandizzi, C., Del Tacca, M., Periodontal tissue disposition of azithromycin (1997) J Periodontol, 68 (12), pp. 1206-1209 Markham, A., McTavish, D., Clarithromycin and omeprazole as helicobacter pylori eradication therapy in patients with H. pylori-associated gastric disorders (1996) Drugs, 51 (1), pp. 161-178 McCracken Jr., G.H., Ginsburg, C.M., Clahsen, J.C., Thomas, M.L., Pharmacologic evaluation of orally administered antibiotics in infants and children: Effect of feeding on bioavailability (1978) Pediatrics, 62 (5), pp. 738-743 Mensa, J., García-Vázquez, E., Vila, J., Macrolides, ketolides and streptogramins (2003) Enferm Infecc Microbiol Clin, 21 (4), pp. 200-207 Moore, T.D., Horton, R., Utrup, L.J., Miller, L.A., Poupard, J.A., Stability of amoxicillin-clavulanate in BACTEC medium determined by high-performance liquid chromatography and bioassay (1996) J Clin Microbiol, 34 (5), pp. 1321-1322 Namour, F., Wessels, D., Reynolds, P., Sultan, E., Lenfant, B., Pharmacokinetics of the new ketolide telithromycin (HMR 3647) administered in ascending single and multiple doses (2001) Antimicrob Agents Chemother, 45 (1), pp. 170-175 Puri, S.K., Lassman, H.B., Roxithromycin: A pharmacokinetic review of a macrolide (1987) J Antimicrob Chemother, 20 (SUPPL. B), pp. 89-100 Ruuskanen, O., Safety and tolerability of azithromycin in pediatric infectious diseases: 2003 update (2004) Pediatr Infect Dis J, 23 (2), pp. S135-9 Saba, J., Morlat, P., Raffi, F., Hazebroucq, V., Joly, V., Leport, C., Vilde, J.L., Pyrimethamine plus azithromycin for treatment of acute toxoplasmic encephalitis in patients with AIDS (1993) Eur J Clin Microbiol Infect Dis, 12 (11), pp. 853-856 Salvador, A.E., Enzler, M.J., The Macrolides: Erythromycin, clarithromycin, and azithromycin (1999) Mayo Clin Proc, 74, pp. 613-634 Tarlow, M.J., Macrolides in the management of streptococcal pharyngitis/tonsillitis (1997) Pediatr Infect Dis J, 16 (4), pp. 444-448 Vester, B., Douthwaite, S., Macrolide resistance conferred by base substitutions in 23S rRNA (2001) Antimicrob Agents Chemother, 45 (1), pp. 1-12 Vilmanyi, E., Kung, K., Riond, J.L., Trumpi, B., Wanner, M., Clarithromycin pharmacokinetics after oral administration with or without fasting in crossbred beagles (1996) J Small Anim Pract, 37 (11), pp. 535-539 Welling, P.G., Interactions affecting drug absorption (1984) Clin Pharmacokinet, 9 (5), pp. 404-434 Welling, P.G., The influence of food on the absorption of antimicrobial agents (1982) J Antimicrob Chemother, 9 (1), pp. 7-27 Welling, P.G., Huang, H., Hewitt, P.F., Lyons, L.L., Bioavailability of erythromycin stearate: Influence of food and fluid volume (1978) Pharm Sci, 67 (6), pp. 764-766 Wise, R., Kirkpatrick, B., Ashby, J., Andrews, J.M., Pharmacokinetics and tissue penetration of roxithromycin after multiple dosing (1987) Antimicrob Agents Chemother, 31 (7), pp. 1051-1053 Yamasaki, O., Akiyama, H., Toi, Y., Arata, J., A combination of roxithromycin and imipenem as an antimicrobial strategy against biofilms formed by Staphylococcus aureus (2001) J Antimicrob Chemother, 48 (4), pp. 573-577